世界のがん治療薬市場2020-2025:化学療法、標的療法、免疫療法、ホルモン療法(生物学的療法)、その他

【英語タイトル】Global Cancer Treatment Drugs Market Growth 2020-2025

LP Informationが出版した調査資料(LPI20AP1016)・商品コード:LPI20AP1016
・発行会社(調査会社):LP Information
・発行日:2020年3月10日
・ページ数:175
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single UserUSD3,660 ⇒換算¥417,240見積依頼/購入/質問フォーム
Multi UserUSD5,490 ⇒換算¥625,860見積依頼/購入/質問フォーム
Corporate UserUSD7,320 ⇒換算¥834,480見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
「がん治療薬の世界市場」は、地域的には米州、アジア、欧州、中東・アフリカ市場をカバーしており、種類別には、化学療法、標的療法、免疫療法、ホルモン療法(生物学的療法)、その他など、用途別には、血液がん、乳がん、消化器がん、前立腺がん、呼吸器・肺がん、その他などに区分してまとめた調査レポートです。がん治療薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が含まれています。
・がん治療薬の世界市場概要(サマリー)
・がん治療薬の企業別販売量・売上
・がん治療薬の企業別市場シェア
・がん治療薬の世界市場規模 2015年-2020年:種類別(化学療法、標的療法、免疫療法、ホルモン療法(生物学的療法)、その他)
・がん治療薬の世界市場規模 2015年-2020年:用途別(血液がん、乳がん、消化器がん、前立腺がん、呼吸器・肺がん、その他)
・がん治療薬の米州市場規模(アメリカ、カナダ、メキシコなど)
・がん治療薬のアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・がん治療薬の欧州市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・がん治療薬の中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・がん治療薬市場の成長要因・課題・動向
・がん治療薬の世界市場予測 2021年-2025年
・がん治療薬の米州市場予測(アメリカ、カナダ、メキシコなど)
・がん治療薬のアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・がん治療薬の欧州市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・がん治療薬の中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・がん治療薬の世界市場予測:種類別(化学療法、標的療法、免疫療法、ホルモン療法(生物学的療法)、その他)
・がん治療薬の世界市場予測:用途別(血液がん、乳がん、消化器がん、前立腺がん、呼吸器・肺がん、その他)
・主要企業分析
【レポートの概要】

According to this study, over the next five years the Cancer Treatment Drugs market will register a 9.1% CAGR in terms of revenue, the global market size will reach $ 209320 million by 2025, from $ 147590 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Cancer Treatment Drugs business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Cancer Treatment Drugs market by type, application, key manufacturers and key regions and countries.

This study considers the Cancer Treatment Drugs value and volume generated from the sales of the following segments:

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Chemotherapy
Targeted Therapy
Immunotherapy
Hormonal Therapy (Biologic Therapy)
Others

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory/Lung Cancer
Other Cancers

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Roche
AstraZeneca
Novartis
Bristol-Myers Squibb
Amgen
Celgene
Takeda
Johnson & Johnson
Eli Lilly
Pfizer
Eisai
Otsuka
Teva
Astellas
Bayer
Sanofi
Ipsen
Biogen Idec
Merck & Co.
Merck KGaA
Gilead Sciences
AbbVie

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Cancer Treatment Drugs consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Cancer Treatment Drugs market by identifying its various subsegments.
Focuses on the key global Cancer Treatment Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Cancer Treatment Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Cancer Treatment Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

【レポートの目次】

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cancer Treatment Drugs Consumption 2015-2025
2.1.2 Cancer Treatment Drugs Consumption CAGR by Region
2.2 Cancer Treatment Drugs Segment by Type
2.2.1 Chemotherapy
2.2.2 Targeted Therapy
2.2.3 Immunotherapy
2.2.4 Hormonal Therapy (Biologic Therapy)
2.2.5 Others
2.3 Cancer Treatment Drugs Consumption by Type
2.3.1 Global Cancer Treatment Drugs Consumption Market Share by Type (2015-2020)
2.3.2 Global Cancer Treatment Drugs Revenue and Market Share by Type (2015-2020)
2.3.3 Global Cancer Treatment Drugs Sale Price by Type (2015-2020)
2.4 Cancer Treatment Drugs Segment by Application
2.4.1 Blood Cancer
2.4.2 Breast Cancer
2.4.3 Gastrointestinal Cancer
2.4.4 Prostate Cancer
2.4.5 Respiratory/Lung Cancer
2.4.6 Other Cancers
2.5 Cancer Treatment Drugs Consumption by Application
2.5.1 Global Cancer Treatment Drugs Consumption Market Share by Type (2015-2020)
2.5.2 Global Cancer Treatment Drugs Value and Market Share by Type (2015-2020)
2.5.3 Global Cancer Treatment Drugs Sale Price by Type (2015-2020)

3 Global Cancer Treatment Drugs by Company
3.1 Global Cancer Treatment Drugs Sales Market Share by Company
3.1.1 Global Cancer Treatment Drugs Sales by Company (2018-2020)
3.1.2 Global Cancer Treatment Drugs Sales Market Share by Company (2018-2020)
3.2 Global Cancer Treatment Drugs Revenue Market Share by Company
3.2.1 Global Cancer Treatment Drugs Revenue by Company (2018-2020)
3.2.2 Global Cancer Treatment Drugs Revenue Market Share by Company (2018-2020)
3.3 Global Cancer Treatment Drugs Sale Price by Company
3.4 Global Cancer Treatment Drugs Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Cancer Treatment Drugs Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Cancer Treatment Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Cancer Treatment Drugs by Regions
4.1 Cancer Treatment Drugs by Regions
4.2 Americas Cancer Treatment Drugs Consumption Growth
4.3 APAC Cancer Treatment Drugs Consumption Growth
4.4 Europe Cancer Treatment Drugs Consumption Growth
4.5 Middle East & Africa Cancer Treatment Drugs Consumption Growth

5 Americas
5.1 Americas Cancer Treatment Drugs Consumption by Countries
5.1.1 Americas Cancer Treatment Drugs Consumption by Countries (2015-2020)
5.1.2 Americas Cancer Treatment Drugs Value by Countries (2015-2020)
5.2 Americas Cancer Treatment Drugs Consumption by Type
5.3 Americas Cancer Treatment Drugs Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Cancer Treatment Drugs Consumption by Regions
6.1.1 APAC Cancer Treatment Drugs Consumption by Regions (2015-2020)
6.1.2 APAC Cancer Treatment Drugs Value by Regions (2015-2020)
6.2 APAC Cancer Treatment Drugs Consumption by Type
6.3 APAC Cancer Treatment Drugs Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Cancer Treatment Drugs by Countries
7.1.1 Europe Cancer Treatment Drugs Consumption by Countries (2015-2020)
7.1.2 Europe Cancer Treatment Drugs Value by Countries (2015-2020)
7.2 Europe Cancer Treatment Drugs Consumption by Type
7.3 Europe Cancer Treatment Drugs Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Cancer Treatment Drugs by Countries
8.1.1 Middle East & Africa Cancer Treatment Drugs Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Cancer Treatment Drugs Value by Countries (2015-2020)
8.2 Middle East & Africa Cancer Treatment Drugs Consumption by Type
8.3 Middle East & Africa Cancer Treatment Drugs Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Cancer Treatment Drugs Distributors
10.3 Cancer Treatment Drugs Customer

11 Global Cancer Treatment Drugs Market Forecast
11.1 Global Cancer Treatment Drugs Consumption Forecast (2021-2025)
11.2 Global Cancer Treatment Drugs Forecast by Regions
11.2.1 Global Cancer Treatment Drugs Forecast by Regions (2021-2025)
11.2.2 Global Cancer Treatment Drugs Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Cancer Treatment Drugs Forecast by Type
11.8 Global Cancer Treatment Drugs Forecast by Application

12 Key Players Analysis
12.1 Roche
12.1.1 Company Information
12.1.2 Cancer Treatment Drugs Product Offered
12.1.3 Roche Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Roche Latest Developments
12.2 AstraZeneca
12.2.1 Company Information
12.2.2 Cancer Treatment Drugs Product Offered
12.2.3 AstraZeneca Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 AstraZeneca Latest Developments
12.3 Novartis
12.3.1 Company Information
12.3.2 Cancer Treatment Drugs Product Offered
12.3.3 Novartis Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Novartis Latest Developments
12.4 Bristol-Myers Squibb
12.4.1 Company Information
12.4.2 Cancer Treatment Drugs Product Offered
12.4.3 Bristol-Myers Squibb Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Bristol-Myers Squibb Latest Developments
12.5 Amgen
12.5.1 Company Information
12.5.2 Cancer Treatment Drugs Product Offered
12.5.3 Amgen Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Amgen Latest Developments
12.6 Celgene
12.6.1 Company Information
12.6.2 Cancer Treatment Drugs Product Offered
12.6.3 Celgene Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Celgene Latest Developments
12.7 Takeda
12.7.1 Company Information
12.7.2 Cancer Treatment Drugs Product Offered
12.7.3 Takeda Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Takeda Latest Developments
12.8 Johnson & Johnson
12.8.1 Company Information
12.8.2 Cancer Treatment Drugs Product Offered
12.8.3 Johnson & Johnson Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Johnson & Johnson Latest Developments
12.9 Eli Lilly
12.9.1 Company Information
12.9.2 Cancer Treatment Drugs Product Offered
12.9.3 Eli Lilly Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Eli Lilly Latest Developments
12.10 Pfizer
12.10.1 Company Information
12.10.2 Cancer Treatment Drugs Product Offered
12.10.3 Pfizer Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Pfizer Latest Developments
12.11 Eisai
12.11.1 Company Information
12.11.2 Cancer Treatment Drugs Product Offered
12.11.3 Eisai Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Eisai Latest Developments
12.12 Otsuka
12.12.1 Company Information
12.12.2 Cancer Treatment Drugs Product Offered
12.12.3 Otsuka Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Otsuka Latest Developments
12.13 Teva
12.13.1 Company Information
12.13.2 Cancer Treatment Drugs Product Offered
12.13.3 Teva Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Teva Latest Developments
12.14 Astellas
12.14.1 Company Information
12.14.2 Cancer Treatment Drugs Product Offered
12.14.3 Astellas Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Astellas Latest Developments
12.15 Bayer
12.15.1 Company Information
12.15.2 Cancer Treatment Drugs Product Offered
12.15.3 Bayer Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 Bayer Latest Developments
12.16 Sanofi
12.16.1 Company Information
12.16.2 Cancer Treatment Drugs Product Offered
12.16.3 Sanofi Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.16.4 Main Business Overview
12.16.5 Sanofi Latest Developments
12.17 Ipsen
12.17.1 Company Information
12.17.2 Cancer Treatment Drugs Product Offered
12.17.3 Ipsen Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.17.4 Main Business Overview
12.17.5 Ipsen Latest Developments
12.18 Biogen Idec
12.18.1 Company Information
12.18.2 Cancer Treatment Drugs Product Offered
12.18.3 Biogen Idec Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.18.4 Main Business Overview
12.18.5 Biogen Idec Latest Developments
12.19 Merck & Co.
12.19.1 Company Information
12.19.2 Cancer Treatment Drugs Product Offered
12.19.3 Merck & Co. Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.19.4 Main Business Overview
12.19.5 Merck & Co. Latest Developments
12.20 Merck KGaA
12.20.1 Company Information
12.20.2 Cancer Treatment Drugs Product Offered
12.20.3 Merck KGaA Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.20.4 Main Business Overview
12.20.5 Merck KGaA Latest Developments
12.21 Gilead Sciences
12.21.1 Company Information
12.21.2 Cancer Treatment Drugs Product Offered
12.21.3 Gilead Sciences Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.21.4 Main Business Overview
12.21.5 Gilead Sciences Latest Developments
12.22 AbbVie
12.22.1 Company Information
12.22.2 Cancer Treatment Drugs Product Offered
12.22.3 AbbVie Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.22.4 Main Business Overview
12.22.5 AbbVie Latest Developments

13 Research Findings and Conclusion



★調査レポート[世界のがん治療薬市場2020-2025:化学療法、標的療法、免疫療法、ホルモン療法(生物学的療法)、その他] (コード:LPI20AP1016)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のがん治療薬市場2020-2025:化学療法、標的療法、免疫療法、ホルモン療法(生物学的療法)、その他]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆